Skip to content

Terrorism-related murder charges dropped by judge, as ruled by Luigi Mangione

In a recent court session, Luigi Mangione, accused of killing UnitedHealthcare CEO Brian Thompson, had his first Manhattan court appearance in five months. During this session, Judge Gregory Carro withdrew two terrorism-related murder charges. More specifically, the judge discarded the most...

Terrorism-related Act: Judge Dismisses Two State Murder Accusations against Luigi Mangione
Terrorism-related Act: Judge Dismisses Two State Murder Accusations against Luigi Mangione

In a significant development, the terrorism charge has been dismissed against Luigi Mangione, the 27-year-old engineer accused of killing UnitedHealthcare CEO Brian Thompson. The dismissal occurred during a court appearance on Tuesday in Manhattan.

The case against Mangione is being prosecuted by the Manhattan District Attorney's Office. The remaining charge against him is second-degree murder, which alleges that he killed Thompson with depraved indifference.

The dismissal of the most severe charge comes after Judge Gregory Carro ruled that the evidence presented to the grand jury was insufficient to support a charge of second-degree murder as a terrorist act. Carro stated that the evidence presented was not enough to support the terrorism charge.

Mangione, who was born in Towson, Maryland, in 1998 and has Italian immigrant roots, is alleged to have assassinated Thompson in Midtown Manhattan on December 4, 2024. He is said to have been motivated by resentment towards the US health insurance industry and corporate greed due to personal grievances related to his own health insurance problems and perceived systemic failures. Mangione viewed health insurance companies as "parasitic" and expressed ideological inspiration partly from Ted Kaczynski's manifesto, aiming to draw attention to the US healthcare system's failings.

During the court appearance, Mangione's attorney, Michael Schmidt, argued for the dismissal of the terrorism charge. The prosecution also presented evidence that Mangione had a history of making threats against UnitedHealthcare executives and a history of mental health issues.

The jury selection for the trial is set to begin on September 20, with the trial itself scheduled to begin on October 4 in Manhattan Criminal Court. Mangione made his first Manhattan courtroom appearance in five months on Tuesday.

This decision to dismiss the terrorism charge is a significant turn in the case against Mangione, and it remains to be seen how the trial will proceed.

Read also:

Latest